BOYNTON ALTON L 4
4 · NORTHWEST BIOTHERAPEUTICS INC · Filed Jul 2, 2020
Insider Transaction Report
Form 4
BOYNTON ALTON L
DirectorChief Executive Officer
Transactions
- Award
Options to purchase Common Stock, par value $0.001
2020-07-02+15,697,693→ 15,697,693 totalExercise: $0.25From: 2020-12-01Exp: 2030-12-01→ Common Stock, par value $0.001 (15,697,693 underlying)
Footnotes (1)
- [F1]These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.